Anticoagulant treatment such as heparin (Tang et al., 2020[17]) and antifibrinolytic therapy tPA (Wang et al., 2020[20]) have been proven to be beneficial for COVID-19 patients with ARDS and effectively reduced mortality. Here, PLAT is linked to acute respiratory distress syndrome.